Yahoo France Recherche Web

Résultats de recherche

1. www.nytimes.com › 2024/06/17 › businessHow A.I. Is Revolutionizing Drug Development - The New York Times

   www.nytimes.com › 2024/06/17 › business

   17 juin 2024 · How A.I. Is Revolutionizing Drug Development. In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting ...

2. www.science.org › doi › 10New government drug repurposing programs: Opportunities and ...

   www.science.org › doi › 10

   Il y a 23 heures · Applications are now closed, but previously, interested parties could propose a project that included conducting clinical trials . Any organization could apply, with an initial aim of a project being to obtain approval for an investigational new drug (IND) application, which is required before clinical trials can begin. NCATS selected projects ...

3. Vidéos

   • 

     46:00

     youtube.com

     Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017

     6 août 2020

     18.3K vues

   • 

     10:03

     youtube.com

     NEW DRUG APPLICATION | REGULATORY AFFAIR

     20 janv. 2022

     11.4K vues

   • 

     1:0:47

     youtube.com

     Understanding New Drug Applications (NDAs)

     17 août 2018

     25.8K vues

   Tout afficher

4. www.pharmexec.com › view › fda-accepts-otsukaFDA Accepts Otsuka and Lundbeck’s Supplemental New Drug ...

   www.pharmexec.com › view › fda-accepts-otsuka

   • En cache

   Il y a 23 heures · The FDA has accepted Otsuka and Lunbdeck’s supplemental New Drug Application for brexpiprazole in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD). The sNDA is supported by data from three randomized clinical trials that evaluated the safety and efficacy of the brexpiprazole-sertraline combination in adult patients with PTSD. 1

5. www.freyrsolutions.com › blog › a-comprehensiveA Comprehensive Guide to Streamline Generic Drug Applications ...

   www.freyrsolutions.com › blog › a-comprehensive

   • En cache

   18 juin 2024 · The process of bringing a generic drug to market is intricate and highly regulated. The Abbreviated New Drug Application (ANDA) is the primary pathway through which generic drug manufacturers seek approval from the U.S. Food and Drug Administration (FDA).

6. techcrunch.com › 2024/06/26 › formation-bio-raisesFormation Bio raises $372M to boost drug development with AI

   techcrunch.com › 2024/06/26 › formation-bio-raises

   • En cache

   Il y a 8 heures · Image Credits: Bryce Durbin / TechCrunch. Formation Bio, a startup focused on applying AI to drug development with backing from OpenAI CEO Sam Altman, has raised over a quarter-billion dollars to ...

7. www.jnj.com › media-center › press-releasesJohnson & Johnson Submits Supplemental New Drug Application ...

   www.jnj.com › media-center › press-releases

   • En cache

   4 juin 2024 · A new co-formulated tablet containing a weight-adjusted pediatric dose (darunavir 675 mg/cobicistat 150 mg) has been developed to aid administration for younger children. The new pediatric tablets are scored to facilitate breaking for ease of swallowing.

8. www.astrazeneca.com › media-centre › press-releasesTagrisso granted Priority Review in the US for patients with ...

   www.astrazeneca.com › media-centre › press-releases

   • En cache

   10 juin 2024 · AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso (osimertinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after chemoradiotherapy (CRT).